Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Premarket analyst action - healthcare

Published 01/04/2018, 07:07 AM
Updated 01/04/2018, 07:07 AM
© Reuters.  Premarket analyst action - healthcare
  • Thermo Fisher (NYSE:TMO), Danaher (NYSE:DHR), Illumina (NASDAQ:ILMN), Agilent (NYSE:A) and Qiagen (NASDAQ:QGEN) all initiated with Outperform rating by Evercore ISI.
  • Cerner (NASDAQ:CERN), athenahealth (NASDAQ:ATHN) and Health Management Systems (NASDAQ:HMSY) all initiated with Neutral ratings by Citigroup (NYSE:C).
  • Humana (NYSE:HUM) added to U.S. 1 List at BofA/Merrill Lynch.
  • Hologic (NASDAQ:HOLX) upgraded to Buy by BofA/Merrill Lynch.
  • Edwards Lifesciences (NYSE:EW) upgraded to Overweight by Barclays (LON:BARC).
  • CVS Health (NYSE:CVS) upgraded to Strong Buy by Raymond James.
  • NuVasive (NASDAQ:NUVA) upgraded to Buy with a $71 (16% upside) price target by Needham.
  • Zoetis (NYSE:ZTS) upgraded to Buy by Citigroup.
  • DaVita (NYSE:DVA) upgraded to Buy by BofA/Merrill Lynch.
  • Teva Pharmaceutical Industries (NYSE:TEVA) upgraded to Buy by Citigroup.
  • Alexion Pharmaceuticals (NASDAQ:ALXN) downgraded to Outperform from Strong Buy by Raymond James.
  • Now read: Sand In My Shoes - What To Do With Frozen Dividends


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.